All News #Library
Biotech
Priovant Expands Brepocitinib to LPP in Phase 2b/3 Trial
02 Apr 2026 //
GLOBENEWSWIRE
Priovant Reports Positive Phase 2 Data For Brepocitinib
06 Feb 2026 //
GLOBENEWSWIRE

Market Place
Sourcing Support